All In Biotech

Drug Trial Radar · NCT07076459

A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Aug 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

Jul 10, 2025

Primary completion

Aug 18, 2025

Study completion Aug 18, 2025

Sponsor

Sponsor type
Industry
First posted
Jul 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the pharmacokinetic characteristics of HR091506 tablets in different batches in healthy subjects after single administration.

Conditions

  • Health Volunteer

Interventions

  • HR091506 tabletDrug

    In each period under fed conditions, subjects received oral administration of either HR091506 tablet(T1), HR091506 tablet(T2), or HR091506 tablet(R).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax: Maximum plasma concentration. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose
  2. AUC0-t: Area under the plasma concentration-time curve from time 0 to the time of the last quantifiable concentration. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose
  3. AUC0-∞: Area under the plasma concentration-time curve from time 0 to infinity. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose
  4. Tmax: Observed time to reach Cmax. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cangzhou Central Hospital

    Cangzhou, Hebei, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.